Back

Lipid management among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Diabetes as a risk factor for heart disease Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Satoshi Shoji

Duke Clinical Research Institute, Durham (United States of America)

8 More presentations in this session

Presentation thumbnail
Prediction of cardiovascular risk in patients type 2 diabetes using the SCORE2-Diabetes risk score
Associate Professor M. Cavender (Chapel Hill, US)
Abstract Slides Video
Presentation thumbnail
DNA methylation in the TXNIP gene is associated with type 2 diabetes in Pacific Peoples living in NZ
Mr S. Gibbs (Christchurch, NZ)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of right and left atrial strain in diabetes mellitus without coronary artery diseases.
Professor M. Matshela (Durban, ZA)
Abstract Slides Video
Presentation thumbnail
Subgroup analysis of diabetes in COVID-positive revascularized patients: implications for clinical management
Doctor Z. Alimli (Baku, AZ)
Abstract Slides Video
Presentation thumbnail
The visceral adiposity index predicts cardiovascular events both in coronary artery disease patients with and in those without diabetes
Associate Professor H. Drexel (Feldkirch, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes as a risk factor for heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Physician disagreement with treatment guidelines as a critical barrier to achieving low-density lipoprotein cholesterol targets in very high-risk patients: an implementation science study
thumbnail
Congress Presentation
Sex-specific guideline target value attainment and prognostic value of low-density lipoprotein cholesterol in tertiary care
thumbnail
Congress Presentation
Lipid goal attainment across baseline socioeconomic and clinical factors comparing an "inclisiran first" implementation strategy and usual care: subgroup analysis of VICTORION-INITIATE

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources